4754
H.-C. Zhang et al. / Tetrahedron Letters 42 (2001) 4751–4754
Marsh, F. D. J. Org. Chem. 1995, 60, 6218; (c) Amat, M.;
10. Larock, R. C.; Yum, E. K. J. Am. Chem. Soc. 1991, 113,
6689.
Hadida, S.; Pshenichnyi, G.; Bosch, J. J. Org. Chem.
1997, 62, 3158; (d) Kawasaki, I.; Yamashita, M.; Ohta, S.
Chem. Pharm. Bull. 1996, 44, 1831; (e) Johnson, C. N.;
Stemp, G.; Anand, N.; Stephen, S. C.; Gallagher, T.
Synlett 1998, 1025.
11. Bergman, J.; Venelman, L. J. Org. Chem. 1992, 57, 2495.
12. Typical procedure for 2,3-diarylindole 11 (Ar1=4-NO2-
C6H4, Ar2=3-thienyl, X=H, Table 2, entry 9): To a
suspension of resin 88d (616 mg, 0.67 mmol; Ar1=4-NO2-
C6H4, X=H) in 20 mL of 1,4-dioxane was added NBS
(475 mg, 2.67 mol). The mixture was stirred at 70°C for
24 h, and then filtered, washed with DMF, MeOH,
CH2Cl2, and Et2O, dried in vacuo to give resin 9 (634
mg). A suspension of resin 9 (150 mg, 0.16 mmol) in
DMF (5 mL) was treated with thiophene-3-boronic acid
(80.6 mg, 0.63 mmol), K2CO3 (65.3 mg, 0.47 mmol), and
Pd(PPh3)4 (18.2 mg, 0.016 mmol). After stirring at 90°C
for 8.5 h, the mixture was filtered, washed sequentially
with DMF, MeOH, CH2Cl2, and Et2O, and dried in
vacuo (145 mg). The resin (140 mg, 0.15 mmol) was
suspended in THF (6 mL) and treated with Bu4NF (1.0
M in THF, 0.76 mL, 0.76 mmol). The mixture was stirred
at 70°C for 5 h and then filtered, washed with THF. The
combined filtrates were evaporated and the residue was
dissolved in EtOAc (100 mL). The solution was washed
with water (5×30 mL), brine (30 mL), and dried
(Na2SO4). Concentration in vacuo furnished 45 mg (93%
yield) of the indole 11 (Ar1=4-NO2-C6H4, Ar2=3-
thienyl, X=H) with 96% purity determined by reverse-
phase HPLC. CI-MS m/z 321 (MH+). The structure was
4. (a) Merlic, C. A.; McInnes, D. M. Tetrahedron Lett.
1997, 38, 7661; (b) Chu, L.; Fisher, M. H.; Goulet, M. T.;
Wyvratt, M. J. Tetrahedron Lett. 1997, 38, 3871; (c)
Smith, A. L.; Stevenson, G. I.; Lewis, S.; Patel, S.;
Castro, J. L. Bioorg. Med. Chem. Lett. 2000, 10, 2693.
5. (a) Joseph, B.; Malapel, B.; Merour, J.-Y. Synth. Com-
mun. 1996, 26, 3289; (b) Malapel-Andrieu, B.; Merour,
J.-Y. Tetrahedron 1998, 54, 11079.
6. Liu, Y.; Gribble, G. W. Tetrahedron Lett. 2000, 41, 8717.
7. For Suzuki coupling reactions on the solid phase, see: (a)
Franzen, R. Can. J. Chem. 2000, 78, 957; (b) Lorsbach,
B. A.; Kurth, M. J. Chem. Rev. 1999, 99, 1549; (c) Guiles,
J. W.; Johnson, S. G.; Murray, W. V. J. Org. Chem.
1996, 61, 5169; (d) Brown, S. D.; Armstrong, R. W. J.
Am. Chem. Soc. 1996, 118, 6331.
8. (a) Zhang, H.-C.; Maryanoff, B. E. J. Org. Chem. 1997,
62, 1804; (b) Zhang, H.-C.; Brumfield, K. K.; Maryanoff,
B. E. Tetrahedron Lett. 1997, 38, 2439; (c) Zhang, H.-C.;
Brumfield, K. K.; Jaroskova, L.; Maryanoff, B. E. Tetra-
hedron Lett. 1998, 39, 4449; (d) Zhang, H.-C.; Ye, H.;
Moretto, A. F.; Brumfield, K. K.; Maryanoff, B. E. Org.
Lett. 2000, 2, 89.
9. (a) Yun, W.; Mohan, R. Tetrahedron Lett. 1996, 37,
7189; (b) Collini, M. D.; Ellingboe, J. W. Tetrahedron
Lett. 1997, 38, 7963; (c) Fagnola, M. C.; Candiani, I.;
Visentin, G.; Cabri, W.; Zarini, F.; Mongelli, N.;
Bedeschi, A. Tetrahedron Lett. 1997, 38, 2307; (d) Aru-
mugam, V.; Routledge, A.; Abell, C.; Balasubramanian,
S. Tetrahedron Lett. 1997, 38, 6473; (e) Smith, A. L.;
Stevenson, G. I.; Swain, C. J.; Castro, J. L. Tetrahedron
Lett. 1998, 39, 8317; (f) Stephensen, H.; Zaragoza, F.
Tetrahedron Lett. 1999, 40, 5799.
1
confirmed by H NMR.
13. Compound 14a (indoxole) is an antiinflammatory agent
with comparable activity to indomethacin in certain anti-
inflammatory and antiarthritic assays: (a) Glenn, E. M.;
Bowman, B. J.; Kooyers, W.; Koslowske, T.; Myers, M.
L. J. Pharmacol. Exp. Ther. 1967, 155, 157; (b) Brune,
K.; Graf, P.; Glatt, M. Agents Actions 1976, 6, 159; (c)
Klug, R. D.; Krohn, D. L.; Breitfeller, J. M.; Dieterich,
D. Ophthalmic Res. 1981, 13, 122.
.